Accordingly, while studies have shown that CCL18 plays a role in fibrotic interstitial lung disease [25,27], higher CCL18 levels have been observed in lung diseases with a prominent lymphocytic inflammatory component, such as sarcoidosis [28]. This evidence concerns the gene CCL18 and lung disorder.